Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015

The report was released in January 2018 by the Centers for Disease Control and Prevention (CDC). The researchers analyzed data from the Truven Health MarketScan Commercial Database. The analysis focused on stimulant prescribing trends between 2003 and 2015 for privately insured women ages 15 to 44 who were diagnosed with attention deficit/hyperactivity disorder (ADHD . . .